FTXH ETF

$39.69

Returns Overview

1 Month
+3.14%
3 Months
+18.75%
6 Months
+18.22%
YTD
+20.31%
1 Year
+49.58%
3 Years (annualized)
+14.68%
5 Years (annualized)
+9.42%

Risk Metrics (1-Year)

No risk data available for this ETF

Stress Test Scenarios

How would FTXH have held up?
🦠COVID-19 Crash33 days
Market peak to trough during pandemic sell-off
Run Analysis
📈2022 Rate Hikes9 months
Fed aggressive rate hiking cycle bear market
🔒Upgrade to run
📉2018 Q4 Selloff3 months
Trade war fears and Fed tightening
🔒Upgrade to run
🏦SVB / Banking Crisis5 days
Regional banking contagion fears
🔒Upgrade to run

1 Month Performance

+3.14%

3 Months Performance

+18.75%

6 Months Performance

+18.22%

1 Year Performance

+49.58%

Benchmark & Peers

Benchmark
Nasdaq US Smart Pharmaceuticals Index(NQSSPH)
This ETF (YTD)
+20.31%
Peer Avg (YTD)
+7.57%
vs Peers
+12.74%

FTXH ETF Performance

FTXH performance across multiple time periods: 1-month 3.14%, YTD 20.31%, 1-year 49.58%, 3-year 14.68%, 5-year 9.42%.

FTXH returns outperform the peer average of 7.57% YTD. With an expense ratio of 0.60%, investors should weigh costs against performance when evaluating this ETF.

FTXH performance comparison shows side-by-side returns with another fund. FTXH alternatives are available in the ETF Screener.

Performance & Returns

Loading chart...

Performance Returns

PeriodTotal ReturnDate Range
1 Month+3.14%Jun 29, 2026 to Jul 28, 2026
3 Months+18.75%Apr 28, 2026 to Jul 28, 2026
6 Months+18.22%Jan 28, 2026 to Jul 28, 2026
1 Year+49.58%N/A
3 Years+14.68%N/A
5 Years+9.42%N/A

Periods up to 1 year are total returns; 3, 5 and 10 year figures are annualized